Dark

QNRX
Quoin Pharmaceuticals, Ltd.
stock NASDAQ ADR

At Close

May 20, 2025 3:59:30 PM EDT

8.30USD+3.880%(+0.31)55,617

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 20, 2025 9:06:30 AM EDT

8.17USD+2.253%(+0.18)3,128

After-hours

May 20, 2025 4:26:30 PM EDT

8.05USD-3.012%(-0.25)150

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

4.88M

Headquarters

23 Hataas St, Kfar Sava, Israel

Industry

Biotechnology

Last Split

Apr 9, 20251for35reverse

QNRX Stats

Avg. Vol. 10 Day

1,011,544

Avg. Vol. 30 Day

375,793

Market Cap

4,881,786

Shares Out.

588,167

On/Off Exchange

66%/34%

6 Month Beta

0.77

1 Year Beta

0.70

2 Year Beta

0.81

3 Year Beta

1.79

52 Week Low

5.01

52 Week High

54.95

SMA50

7.79

SMA200

16.79

1 Week

+30.50%

1 Month

+46.38%

3 Month

-28.74%

6 Month

-62.09%

1 Year

-69.01%

2 Year

-95.81%

5 Year

-100.00%

Profile

cellect biotechnology was founded in 2011 with a mission to become a global leader in the next generation of cellular therapies by developing innovative solutions for immune system regeneration. achieving higher selectivity, greater specificity and decreased toxicity, cellect envisions its products becoming an integral and essential part of bone marrow transplantation (bmt), as well as integrated into many aspects of regenerative medicine.

QNRX Stock Summary

Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) stock price today is $8.30, and today's volume is 55,617. QNRX is up 3.880% today. The 30 day average volume is 375,793. QNRX market cap is 4.88M with 588,167 shares outstanding.

.dark-mode .mmfKhY{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .mmfKhY{ color: #333333; background-color: white; border: 2px solid #333333; }QNRXQuoin Pharmaceuticals, Ltd.stock NASDAQ ADR

QNRX Stock Summary

QNRX
Quoin Pharmaceuticals, Ltd.
stock NASDAQ ADR